To further confirm AP-2α controls NPC cell growth via the modulation of the COX-2 signaling, we next detected the effect of Celebrex (CB), a COX-2-selective inhibitor, on NPC cell growth. Here, PTGS2 is linked to nasopharyngeal carcinoma.